Literature DB >> 4427984

Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals.

M A Schwartz, A M Aikens, R J Wyatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4427984     DOI: 10.1007/BF00429129

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  18 in total

Review 1.  STORAGE AND METABOLISM OF CATECHOLAMINES: THE ROLE OF MONOAMINE OXIDASE.

Authors:  I J KOPIN
Journal:  Pharmacol Rev       Date:  1964-06       Impact factor: 25.468

2.  The distribution of monoamie oxidae and succinic oxidase in brain.

Authors:  N WEINER
Journal:  J Neurochem       Date:  1960-08       Impact factor: 5.372

3.  The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain.

Authors:  D F BOGDANSKI; H WEISSBACH; S UDENFRIEND
Journal:  J Neurochem       Date:  1957       Impact factor: 5.372

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.

Authors:  D L Murphy; R J Wyatt
Journal:  Nature       Date:  1972-07-28       Impact factor: 49.962

6.  Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients.

Authors:  E F Domino; R R Krause; J Bowers
Journal:  Arch Gen Psychiatry       Date:  1973-08

7.  Genetic control of platelet and plasma monoamine oxidase activity.

Authors:  A Nies; D S Robinson; K R Lamborn; R P Lampert
Journal:  Arch Gen Psychiatry       Date:  1973-06

8.  The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

9.  Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.

Authors:  R J Wyatt; D L Murphy; R Belmaker; S Cohen; C H Donnelly; W Pollin
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients.

Authors:  C D Wise; L Stein
Journal:  Science       Date:  1973-07-27       Impact factor: 47.728

View more
  4 in total

Review 1.  Physiological and pathological changes in tissue monoamine oxidase activity.

Authors:  M B Youdim; M Holzbauer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

2.  Monoamine oxidase A deficit in liver of germ-free rats.

Authors:  M A Reveley; V Glover; M Sandler; M E Coates
Journal:  Experientia       Date:  1983-05-15

3.  Changes in responses of neurons to serotonin produced by blood serum from schizophrenics.

Authors:  E I Solntseva; G N Korobtsov
Journal:  Neurosci Behav Physiol       Date:  1979 Oct-Dec

4.  [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].

Authors:  G Schneider; H Oepen; H R von Wedel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.